Postmenopausal Osteoporosis (PMO)
2 clinical trials · Condition
◉ Watch Postmenopausal Osteoporosis (PMO)
| Record | Firm | Date |
|---|---|---|
| Efficacy, Safety and Tolerability of Romosozumab in the Treatment of Japanese Women With Postmenopausal Osteoporosis (NCT01992159) | Amgen | 2012-10-12 |
Track Postmenopausal Osteoporosis (PMO) automatically
Every clearance here is in the API, with alerts when new ones post.